Equest 18.92mg/g Horse Wormer Gel 14.8g

EQUEST Oral Gel is effective against benzimidazole resistant strains of cyathostomes. Mares may be treated at any stage of pregnancy and lactation.

For oral administration. A single oral dose of 400 µg moxidectin/kg bodyweight using the calibrated syringe. Before the first dose, hold the syringe with the capped end pointing to the left and so that you can see the weight measurements and tick marks (small black lines). Set the syringe to zero by moving the dial ring so that the left side is set at the first full black mark and depress the plunger, safely discarding any paste that is expelled.

To dose the product, hold the syringe as previously described. Each tick mark relates to 25 kg bodyweight and to 10 mg moxidectin. Turn the dial ring until the left side of the ring lines up with the weight of the animal.

Use of a scale or weigh tape is recommended to ensure accurate dosing.

A single syringe treats a 700 kg horse.

To avoid overdosing, care should be taken to accurately dose foals, especially low bodyweight foals or young ponies.

Do not administer to young foals less than 4 months of age.

Do not administer in case of known hypersensitivity to the active ingredient or to any other milbemycins and to any other ingredients of the veterinary medicinal product.

EQUEST Oral Gel has been formulated specifically for use in horses only. Dogs or cats may be adversely affected by the concentration of moxidectin in this product if they are allowed to ingest spilled gel or have access to used syringes. Neurological signs (such as ataxia, muscle tremor and convulsions) and digestive clinical signs (such as hypersalivation) were recorded.

Do not use the same syringe to treat more than one animal unless horses are running together or in direct contact with each other on the same premises.

Ataxia, depression, abdominal pain, muscle tremor, flaccid lower lip and swelling of the muzzle could be observed on very rare (less than 1 animal in 10,000 animals treated, including isolated reports) occasions. These adverse effects are usually transient and disappear spontaneously in most cases.

Do not smoke, drink or eat while handling the product.

The use of protective gloves is recommended.

Wash hands or any exposed area after use.

Avoid direct contact with skin and eyes.

In the event of eye contact, flush the eye with copious amounts of clean water and seek medical advice.

EQUEST Oral Gel contains 18.92 mg/g moxidectin. Also contains 37.84 mg/g benzyl alcohol and 0.24 mg/g disodium edetate as preservatives.